Autolus raises $150M in upsized IPO

Autolus Therapeutics plc (NASDAQ:AUTL) climbed $8 (47%) to $25 its first day of trading on June 22 after it raised $150 million via the sale of 8.8 million ADSs at $17 in an upsized IPO. Underwriters are Goldman Sachs, Jefferies, Wells Fargo and William Blair.

The price, which was at the top end of Autolus' proposed range of $15-$17, valued the company at $659.4 million...